tiprankstipranks
Trending News
More News >
Sapporo Clinical Laboratory Center, Inc. (JP:9776)
:9776
Japanese Market

Sapporo Clinical Laboratory Center, Inc. (9776) Financial Statements

Compare
0 Followers

Sapporo Clinical Laboratory Center, Inc. Financial Overview

Sapporo Clinical Laboratory Center, Inc.'s market cap is currently ¥3.46B. The company's EPS TTM is ¥31.13; its P/E ratio is 6.85; and it has a dividend yield of 2.26%. Sapporo Clinical Laboratory Center, Inc. is scheduled to report earnings on May 12, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 20.13B¥ 19.68B¥ 20.13B¥ 19.11B¥ 17.50B
Gross Profit¥ 5.95B¥ 5.90B¥ 6.30B¥ 6.32B¥ 5.73B
Operating Income¥ 706.08M¥ 534.50M¥ 1.01B¥ 1.54B¥ 1.14B
EBITDA¥ 1.27B¥ 1.14B¥ 1.49B¥ 2.06B¥ 1.45B
Net Income¥ 464.18M¥ 380.16M¥ 568.62M¥ 1.04B¥ 793.69M
Balance Sheet
Cash & Short-Term Investments¥ 2.94B¥ 3.98B¥ 3.66B¥ 2.99B¥ 2.36B
Total Assets¥ 16.45B¥ 16.68B¥ 16.52B¥ 16.15B¥ 14.51B
Total Debt¥ 1.93B¥ 2.20B¥ 2.43B¥ 2.58B¥ 2.10B
Net Debt¥ -1.01B¥ -1.78B¥ -1.23B¥ -407.62M¥ -256.99M
Total Liabilities¥ 5.06B¥ 5.50B¥ 5.64B¥ 5.81B¥ 5.24B
Stockholders' Equity¥ 11.15B¥ 10.94B¥ 10.59B¥ 10.11B¥ 9.27B
Cash Flow
Free Cash Flow¥ -491.26M¥ 629.92M¥ 604.44M¥ 625.26M¥ -2.32B
Operating Cash Flow¥ 730.91M¥ 1.08B¥ 1.43B¥ 1.57B¥ 837.59M
Investing Cash Flow¥ -1.24B¥ -395.47M¥ -409.03M¥ -830.96M¥ -3.15B
Financing Cash Flow¥ -525.74M¥ -369.96M¥ -347.89M¥ -112.74M¥ 1.94B
Currency in JPY

Sapporo Clinical Laboratory Center, Inc. Earnings and Revenue History

Sapporo Clinical Laboratory Center, Inc. Debt to Assets

Sapporo Clinical Laboratory Center, Inc. Cash Flow

Sapporo Clinical Laboratory Center, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis